Amgen Inc.
HIGH TITER RECOMBINANT AAV VECTOR PRODUCTION IN ADHERENT AND SUSPENSION CELLS
Last updated:
Abstract:
Disclosed are an in vitro method of producing a recombinant AAV virion in a mammalian host cell that comprises a functional adenoviral E1A gene (e.g., a HEK 293 cell) and rAAV virions made by the method.
Status:
Application
Type:
Utility
Filling date:
28 Jul 2021
Issue date:
25 Nov 2021